Vascular responses to endothelium-dependent vasodilators are greatly impaired in vivo, while isolated blood vessels from animals with diabetes mellitus demonstrate less consistent degrees of impairment. Glycation of proteins, such as hemoglobin, has been implicated in the vascular abnormalities associated with diabetes. Objective: The purpose of this study was to test the hypothesis that glycosylated hemoglobin is capable of reducing endothelium-dependent vasodilator responses, possibly explaining impaired dilation observed in vivo.
Introduction
Diabetes mellitus is associated with increased cardiow x vascular morbidity and mortality 1-3 . Reasons for the increased morbidity and mortality are uncertain, but impairment of endothelial function and platelet-endothelium w x interactions are likely contributing factors 4-7 . In animals and patients with diabetes, endothelial modulation of vascular responses is impaired to endogenous vasodilators Ž . w x such as acetylcholine Ach and adenosine 8,9 . Several investigators have observed an impaired response to Ach in vitro which occurred due to endothelial production of vasoconstrictor prostanoids such as TX A and PGH 2 2 w x 4,5,7 . Others have suggested that oxygen-derived free radicals may play an important role in the reduced dilation w x 8,10-12 . Despite these in vitro abnormalities, in vivo vascular responses in diabetes are more often and more severely attenuated than those observed in vitro. The reason for this discrepancy is uncertain.
Since long-term hyperglycemia appears to be the central initiating factor responsible for the development of many w x of the complications of diabetes 4,9,13 , glucose or glucose-derived metabolites may irreversibly modify longlived extracellular or intracellular macromolecules which w x can inactivate nitric oxide 14 . Thus, a circulating factor or factors may play a role in endothelial dysfunction associated with diabetes. A recent study by Rodriguezw x Manas 15 and colleagues suggests that high levels of glycosylated hemoglobin impair endothelium-mediated vasoactive responses in rat aorta. This study is consistent with the hypothesis that glycosylated hemoglobin, a factor present in vivo, is responsible for impaired coronary mi-( )crovascular responses during hyperglycemia. To test this hypothesis, the effect of glycosylated hemoglobin on endothelium-dependent vasodilatation was studied in several vascular beds, including ventricular microvessels and coronary, mesenteric, femoral, and renal conduit arteries. Ž . solution see solutions for dissection. Ventricular arterioles and arteries were dissected and trimmed of fat and connective tissue. In some studies of rings, the endothelium was removed by gentle rubbing of the luminal surface with silk suture.
Methods

All
Isolated microÕessels
A standard isolated pressurized arteriole preparation w x was used to study coronary microvessels 16 . Each end of the arteriole was cannulated with a glass micropipette and Ž attached to independent hydrostatic pressure reservoirs 20 . mmHg under conditions of no flow. The organ chamber was placed on the stage of an inverted microscope. Attached to the microscope were a video camera, a video monitor, and a calibrated video calliper. The organ chamber was connected to a rotary pump which continuously circulated oxygenated Krebs buffer warmed to 378C. Internal diameters were measured by manually adjusting the video micrometer.
Arterioles 
Isolated Õascular rings
Coronary, femoral, mesenteric and renal arteries were w x studied using a standard isometric ring technique 10,17 . Vascular rings were mounted on two stirrups made by passing stainless steel wires through the vessel lumen. One stirrup was attached to a force transducer, and the other to a micrometer microdrive to allow the vessel to be stretched by known increments. Each vessel apparatus was placed in a 25-ml jacketed organ bath containing Krebs buffer equilibrated at 378C and aerated with 20% O , 5% CO and . response curve to SNP 10 to 10 M was then performed to evaluate smooth muscle vasodilatation. The order of Ach and SNP was randomized. Acceptable experi-Ž . ments met the following criteria: 1 development of ) 1 g Ž . Ž . of tension to PGF ; 2 dilate by 75-150% to SNP; 3 2 a Ž y6 . denuded vessels must dilate -30% to Ach 10 M . glucose 11. Solutions were aerated with 20% O , 5% CO , 2 2 and 75% N and maintained at 378C with pH maintained 2 at 7.4. Human hemoglobin solutions were purchased from Ž . Sigma Chemical St. Louis, MO and prepared by diluting in distilled H O. Glycosylated hemoglobin content was 2 quantified in the clinical pathology laboratory at the University of Iowa. Endothelin-1 was purchased from Cal-Ž . biochem San Diego, CA . All solutions and vasoactive agents were prepared fresh on the day of the experiment. Acetylcholine and sodium nitroprusside were purchased from Sigma Chemical. with a one-way ANOVA. Data are expressed as mean " s.e.m. Differences with P -0.05 were considered significant.
Solutions and drugs
Results
Coronary microÕascular responses
Baseline diameter was 123 " 12, 105 " 13, and 117 " 9 mm for arterioles in control, nGH, and GH groups respec-Ž . tively P s n.s. . Arterioles in all groups were precon-Ž stricted with similar amounts with endothelin 0.40-8.0
. nM . Arterioles were preconstricted to 49 " 3, 51 " 4, and 55 " 2% resting diameter in control, nGH, and GH groups, Ž . respectively P s n.s. . Ach produced concentration-related relaxation in canine coronary arterioles. These responses were not affected by incubating the microvessels Ž . in 1 nM nGH or GH Fig. 1 ACh were y6.3 " 0.1, y7.0 " 0.3, and y6.4 " 0.1 for control, 1 nM nGH and 1 nM GH, respectively. The response to Ach in vessels which were incubated in 10 nM Ž . GH was reduced compared to control Fig. 1, right panel . A similar reduction in dilation to Ach was seen in arteri-Ž . oles incubated with 10 nM nGH Fig. 1 , right panel . EC 50 Fig. 1 . Ach-induced relaxation of canine ventricular microvessels in the presence of nGH and GH. The microvessels were precontracted with endothelin-1. The left panel shows concentration-response curves to Ach in the presence of 1 nM concentrations of the nGH and GH solution. No differences were observed in Ach-induced vasodilatation. In the presence Ž . of 10 nM nGH and GH right panel , the response to Ach of both treatment curves was attenuated compared to the control curve. Thus, in Ž . canine coronary microvessels, GH 10 nM caused a non-specific impairment of Ach responses. ) P -0.05 vs control. The left panel demonstrates concentration-response curves to Ach in the presence of 10 nM concentrations of the nGH and GH solution. The right panel shows the response to Ach in the presence of 100 nM nGH and GH. There were no differences in sensitivity or maximal relaxation responses of Ach in the presence of 10 or 100 nGH or GH. In arteries in which the endothelium had been removed, the response to Ach was Ž ) . significantly attenuated in both groups P -0.05 .
values for ACh were y8.2 " 0.3, y6.8 " .03, and y6.8 " 0.1 for control, 10 nM nGH and 10 nM GH, respec-Ž . tively P -0.05 SNP produced a concentration-related increase in diameter in coronary arterioles. These responses were not altered by the presence of 1 or 10 nM hemoglobin solutions Ž . data not shown .
The decrease in sensitivity of the arterioles to Ach in the presence of 10 nM nGH or GH suggests a non-specific effect of hemoglobin on Ach responses.
Coronary artery responses
Coronary artery segments were taken from the left circumflex and left anterior coronary arteries. Resting tension was 6.5 " 0.2, 5.7 " 0.3, 5.5 " 0.2, and 5.2 " 0.2 g in Ž control, nGH, GH and denuded groups respectively P s . n.s. . Developed tension to PGF was similar among 2 a groups and 3.6 " 0.3, 3.9 " 0.4, 4.5 " 0.5, and 3.5 " 0.9 g in control, nGH, GH and denuded groups, respectively; P s n.s.. In canine coronary arteries preconstricted with Ž . PGF , Ach Fig. 2 and SNP produced concentration-re-2 a lated relaxation. Vessels incubated in 10 or 100 mM GH or nGH did not show an altered response to Ach or SNP. EC values for ACh and SNP were not altered by the 50 Ž . presence of 10 or 100 nM GH or nGH data not shown . Following endothelial removal, the response to Ach was significantly reduced. Endothelium removal did not alter the response to SNP.
Femoral artery responses
Resting tension was 5.8 " 0.4, 6.0 " 0.2, 6.1 " 0.2, and 5.7 " 0.5 g in control, nGH, GH and denuded groups, Number of vessel segments represented for Ach data are the same as in Fig. 3 .
Ž . respectively P s n.s. . All femoral segments constricted Ž similarly to PGF 3.7 " 0.4, 5.7 " 0.4, and 3.7 " 1.0 g 2 a in nGH, GH and denuded groups, respectively; P s n.s. vs . control 5.2 " 0.7 . In canine femoral arteries preconstricted Ž . with PGF , Ach and SNP Table 1 produced concentra-2 a tion-related relaxation. In arteries denuded of endothelium, the response to Ach was significantly impaired. Femoral artery response to ACH in the presence of 100 nM nGH and GH is shown in Fig. 3 . Vessels incubated in 10 or 100 mM GH or nGH did not show altered responses to Ach or SNP. Endothelium removal did not alter the response of the vessels to SNP. EC values are presented in Table 1 . shows the response of femoral artery segments to Ach in the presence of 100 nM nGH and GH. The left panel shows the response to Ach in the presence of 100 nM nGH and GH. There were no differences in sensitiv-Ž ity or maximal relaxation responses of Ach in the presence of 10 data . not shown or 100 nGH or GH. In arteries in which the endothelium had been removed, the response to Ach was significantly attenuated in both Ž ) . groups P -0.05 . Number of vessel segments represented for Ach data are the same as in Fig. 3 .
Mesenteric artery responses
Resting tension was 6.1 " 0.2, 5.8 " 0.3, 6.1 " 0.2, and 6.4 " 0.2 g in control, nGH, GH and denuded groups, respectively. Developed tension to PGF was 5.2 " 0.5, 2 a 5.7 " 0.8, 7.3 " 0.8, and 4.7 " 0.9 g in control, nGH, GH Ž . Ž . and denuded groups, respectively P s n.s. . Ach Fig. 3 Ž . and SNP Table 2 produced concentration-related relaxations which were not altered by the presence of 10 or 100 nM GH and nGH. Dilation to Ach was significantly impaired, but the response to SNP was not affected by endothelium removal. EC 's are presented in Table 2 . 
Renal artery responses
In canine renal artery segments, developed tension to PGF was 7.1 " 0.6, 6.3 " 0.8, and 8.4 " 1.0 g in control, 2 a Ž . nGH, and GH groups, respectively P s n.s. . Preconstricted renal artery segments produced concentration-related relaxation to Ach and SNP. The presence of 100 nM GH and nGH did not alter the response to Ach or SNP Ž . Table 3 . 
Discussion
There are three major findings of the present study. First, glycosylated hemoglobin at concentrations expected in diabetic patients and at concentrations considered supraphysiological for diabetes fails to attenuate conduit artery dilation to Ach in the coronary, mesenteric, femoral or renal vascular beds. Second, the effect of hemoglobin on vascular reactivity varies according to vessel size in the coronary bed. Third, the impaired coronary microvascular responses to Ach in the presence of nGH and GH appears not to be related to glycosylation of hemoglobin. It appears to be an effect that is related to hemoglobin per se, as previously discussed. These results suggest that circulating factors other than glycosylated hemoglobin are responsible for the impaired endothelium-dependent vasodilatation observed in diabetic subjects, in vivo. Our results and conclusions are dependent upon several methodological considerations.
We used standard in vitro preparations to study isolated w x ventricular coronary microvessels 16 and conduit arteries from the coronary, mesenteric, femoral and renal vascular w x beds 10,15,17 . These methods have been used by several w x laboratories, including our own 17 . The concentration of Ž . GH we used was high 14% . However, it reflects the degree of glycosylated hemoglobin seen in diabetic subw x jects 18-20 . In our study, there were no differences in dilation to Ach among vessels treated with nGH or GH Ž . see Figs. 1-3 . Furthermore, in coronary, femoral, mesenteric and renal artery segments, endothelium-dependent responses were not altered by the presence of 10 or even 100 nM GH or nGH. In normal subjects, free plasma hemoglobin in the nanomolar concentrations has been w x reported 21 . Thus, the use of concentrations greater than 100 nM GH would not provide useful physiological information.
Hemoglobin has been used to inhibit endothelium-dependent nitric oxide relaxations in several vascular beds, w x w x including coronary arteries 22 and rabbit aorta 23 . Myw x ers et al. 16 have shown concentrations of 10 mM hemoglobin to inhibit Ach relaxation in canine coronary microvessels. Lower concentrations of hemoglobin were w x not investigated in that study 16 . In our study, both 10 nM nGH and GH attenuated the relaxation to Ach in ventricular microvessels. The effect appears specific for endothelium-dependent responses, since smooth muscle responses were not altered by the presence of nGH or GH. w x The results of Rodriguez-Manas et al. 15 contrast with the findings of the current study. Segments of rat aorta which were incubated in 10 nM GH solution for 10 min showed decreased responses to Ach. Our study suggests Ž that even with 10-fold higher concentrations of GH 100 . nM , endothelium-dependent responses in canine arteries were not altered. Several potential explanations exist for these results which contrast with those of RodriguezManas. First, in our study a different species of animal was studied. Second, in their isolated aortic ring studies, the organ chambers were aerated with 95% O and 5% CO , 2 2 while we used a gaseous mixture containing 20% O , 5% 2 CO and 75% N . It is well established that oxygen-de- 2 2 rived free radicals are produced by auto-oxidation of gluw x cose 4,10,11 . These reactive oxygen species may combine with the NO, producing a relatively weak vasodilator, w x peroxynitrite 24 . Third, agents used to preconstrict the Ž . w x vessels were different PGF vs norepinephrine 17,25 .
a
Finally, we investigated the reactivity of conduit vessels from the coronary, mesenteric, femoral and renal vascular beds in addition to coronary microvessels, whereas Rodriguez-Manas et al. studied aortic segments. It is possible that responses are different in regional organ blood vessels.
This study was intended to shed light on the discrepancies observed between in vivo and in vitro preparations which evaluate vascular responses in diabetes. Our study fails to provide an explanation for this discrepancy. It is possible that glycation of other circulating proteins within the serum of diabetic individuals may be responsible for the abnormalities in endothelium-dependent vasodilatation observed in vivo in diabetic subjects. Further studies are necessary to clarify this possibility.
In summary, in dog coronary arterioles, and coronary, mesenteric, femoral and renal arteries, GH is not responsible for the impaired endothelium-dependent vasodilatation in response to Ach associated with diabetes mellitus. 
